Sun Pharma shares rise on ₹3,000 Cr capex announcement
pre-market1 source ↓written by the desknot a recommendation
- capex plan
- ₹3,000 cr
- day high
- ₹1,815.95
- increase
- 1%
- previous close
- ₹1,798.05
- market cap
- ₹4,29,409 cr
Sun Pharmaceutical Industries is gaining attention following its announcement of a ₹3,000 cr capex plan to establish a new greenfield formulations plant. The stock reached a day high of ₹1,815.95, reflecting a 1% increase from the previous close of ₹1,798.05. This strategic investment may enhance production capacity and drive future growth. 📈
With a market cap of ₹4,29,409 cr, Sun Pharma has delivered a 214% return over five years, significantly outperforming the NIFTY 50's 96% return.
Not investment advice. For informational purposes only.